![Matthew Sobczyk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 697 $ al 30/09/2026
Matthew Sobczyk is currently Chief Financial Officer at Profound Medical Corp.
since 2026.
Mr. Sobczyk completed undergraduate studies at Richard Ivey School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/09/2026 | 1.327 ( 0 % ) | 7 697 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROFOUND MEDICAL CORP. | Director Financiero/CFO | 14/08/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Profound Medical Corp.
 Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
